摘要
支气管内超声引导经支气管淋巴结针吸活检术(EBUS-TBNA)是肺癌纵隔淋巴结分期的新方法,其具有微创、安全等特点,进行纵隔淋巴结分期具有较高的灵敏度和特异度,优于CT、PET和经支气管淋巴结针吸活检术(TBNA),和纵隔镜相当,联合EBUS-TBNA和经食管内镜超声引导细针抽吸活检术(EUS-FNA)可获得几乎完全的纵隔淋巴结分期。可一线应用于肺癌的纵隔淋巴结分期及纵隔淋巴结病变活检。EBUS-TBNA不足之处是相对较高的假阴性率,对于阴性患者,建议行进一步的侵袭性分期方法如纵隔镜检查。
Endobronchial ultrasound-guided transbronchial needle aspiration(EBUS-TBNA) is a novel approach for mediastinal lymph node staging in lung cancer,with minimal invasiveness and good safety.EBUS-TBNA shows distinct advantages in sensitivity and specificity over CT,PET and conventional transbronchial needle aspiration(TBNA) for mediastinal lymph node staging,and may be a viable alternative to mediastinoscopy.Combination of EBUS-TBNA and transesophageal endoscopic ultrasound-guided fine-needle aspiration(EUS-FNA) may allow for nearly complete staging of the mediastinum,and therefore can be a first-line choice for lymph node staging and mediastinal lymph node biopsy.Owing to a relatively high rate of false negative results,patients who test negative by EBUS-TBNA may need further invasive procedures(such as mediastinoscopy) for a confirmation.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2010年第12期1138-1140,共3页
Chinese Journal of Practical Internal Medicine
关键词
活组织检查
针吸
肺癌
纵隔淋巴结分期
biopsy
needle
lung cancer
mediastinal lymph node staging